Tag: alzheimer

Antipsychotic Safe, Effective for Dementia-Related Psychosis

Continued treatment with the atypical antipsychotic pimavanserin (Nuplazid) reduces risk for recurring delusions and hallucinations related to dementia, new data reveal. Phase 3 results from...

Zero Benefit of Aducanumab for Alzheimer’s Disease, Panel Rules

An influential, independent panel unanimously voted that aducanumab (Aduhelm) offers no benefit for patients with Alzheimer’s disease (AD), adding to growing opposition from medical experts...

Can Removing Urban Highways Improve the Health of US Cities?

Mandela Parkway, a four-lane boulevard enhanced by a median with trees and a curving footpath, stretches along a 24-block section of West Oakland. It’s the...

Medicare Mulls Coverage for New Alzheimer’s Drug

By Robin FosterHealthDay Reporter TUESDAY, July 13, 2021 (Healthday News) — Medicare launched a formal process on Monday that will determine whether the agency will...

Why Some Patients Say Yes

July 7, 2021 — Rolfe Johnson is a glass-half-full kind of guy, but also a realist. As a longtime attorney in Houston, only recently...

Chronic Stress, Genetics May Raise Alzheimer’s Risk

A review of human and animal epidemiological studies found that long-term stress and genetic factors may act through the hypothalamic-pituitary-adrenal (HPA) axis ¢a pathway in...

No Overall Statin Effect Seen on Dementia, Cognition

Statin therapy likely didn’t lead to dementia or even mild cognitive impairment (MCI) in older patients taking the drugs for cardiovascular (CV) primary prevention in...

Antihypertensives Crossing Blood-Brain Barrier Improves Memory

Antihypertensive medications that cross the blood-brain barrier (BBB) may be linked with less memory decline, compared with other drugs for high blood pressure, suggest the...

US Hitting Encouraging Milestones on Virus Deaths and Shots

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. COVID-19 deaths in the U.S. have dipped below 300 a day...

Consumer Advocacy Group Wants FDA Leaders Ousted Over Alzheimer’s Drug Approval

Advocates Who Backed Approval Decry Cost Aducanumab had a rocky road to approval but had unwavering backing from the Alzheimer’s Association and at...

Watchdog Group Wants FDA Leaders Removed for Okaying Aducanumab

A high-profile, Washington-based consumer advocacy group is calling for the removal of the US Food and Drug Administration’s (FDA’s) acting commissioner and two other top...

Two FDA Panel Members Resign Over Alzheimer’s Drug Approval

Two members of the US Food and Drug Administration’s (FDA’s) Peripheral and Central Nervous System Drugs Advisory Committee have resigned following the agency’s approval of...

Healthy Lifestyle Tied to Reduced Dementia Despite Family History

Individuals at increased risk for dementia because of family history can reduce that risk by adopting healthy lifestyle behaviors, data from more than 300,000 adults...

‘Precision’ Nutrition? DHA Benefit Modified by AD Genetic Risk

In cognitively unimpaired middle-aged adults at high genetic risk for Alzheimer’s disease (AD), higher intake of dietary docosahexaenoic acid (DHA) was associated with greater resistance...

When to Refer Patients With New Memory Loss

Asking a patient who has concerns about memory loss particular questions can guide referral decisions, according to new research. Initial questions should zero in on...

Once-Nightly Sodium Oxybate Agent Effective in Narcolepsy

A novel, once-nightly formulation of sodium oxybate is safe and effective for treating both subjective and objective symptoms of narcolepsy, new research suggests. Top-line results...

Eating More Fat May Boost Borderline Low Testosterone

“Low-fat diets appear to decrease testosterone levels in men, but further randomized controlled trials are needed to confirm this effect,” the authors of a meta-analysis...

Famed Animal Expert Jack Hanna Diagnosed With Dementia

Jack Hanna, the director emeritus of Ohio’s Columbus Zoo and Aquarium known for his many TV appearances, has been diagnosed with dementia, his family announced...

Cancer Drug Promising for Alzheimer’s Disease

A cancer drug used in various types of leukemia to prevent infection is showing promise in Alzheimer’s disease (AD), results of a phase 2 randomized...

Simple Blood Test Plus AI May Flag Early Stage Alzheimer’s

A minimally invasive blood test along with artificial intelligence (AI) may flag early-stage Alzheimer’s disease (AD), raising the prospect of early intervention when effective treatments...

Despite Risks, Warnings, CNS Polypharmacy Prevalent in Dementia

A significant proportion of community-dwelling older adults with dementia take three or more central nervous system (CNS) medications despite guidelines that say to avoid this...

Novel Alzheimer’s Drug Slows Cognitive Decline in Phase 2 Trial 

Results from a phase 2 placebo-controlled trial of the investigational antiamyloid drug donanemab show that the novel agent met the primary outcome of slowing cognitive...

Alzheimer’s Patients Often Given Too Many Meds

By Dennis Thompson HealthDay Reporter WEDNESDAY, March 10, 2021 (HealthDay News) — Many older adults with dementia are prescribed dangerous combinations of drugs that raise...

Black, Hispanic Communities’ Concern Over Dementia

By Dennis Thompson HealthDay Reporter TUESDAY, March 2, 2021 (HealthDay News) — Black and Hispanic Americans already face higher risks for dementia than the general...

500,000 Americans Now Dead from COVID-19

It’s the national record no one is celebrating: The American COVID-19 death toll has crossed the 500,000 mark. The novel coronavirus is now the third leading cause...